TY - JOUR
T1 - Erratum to ‘Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer
T2 - The CATS international database’ [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163] (European Journal of Cancer (2020) 125 (153–163), (S0959804919308020), (10.1016/j.ejca.2019.10.030))
AU - Delanoy, Nicolas
AU - Hardy-Bessard, Anne Claire
AU - Efstathiou, Eleni
AU - Moulec, Sylvestre Le
AU - Basso, Umberto
AU - Birtle, Alison
AU - Thomson, Alastair
AU - Krainer, Michael
AU - Guillot, Aline
AU - Giorgi, Ugo De
AU - Hasbini, Ali
AU - Daugaard, Gedske
AU - Bahl, Amit
AU - Chowdhury, Simon
AU - Caffo, Orazio
AU - Beuzeboc, Philippe
AU - Spaeth, Dominique
AU - Eymard, Jean Christophe
AU - Fléchon, Aude
AU - Alexandre, Jerome
AU - Helissey, Carole
AU - Butt, Mohamed
AU - Priou, Frank
AU - Lechevallier, Eric
AU - Deville, Jean Laurent
AU - Gross-Goupil, Marine
AU - Morales, Rafael
AU - Thiery-Vuillemin, Antoine
AU - Gavrikova, Tatiana
AU - Barthélémy, Philippe
AU - Sella, Avishay
AU - Fizazi, Karim
AU - Ferrero, Jean Marc
AU - Laguerre, Brigitte
AU - Thibault, Constance
AU - Hans, Sophie
AU - Oudard, Stéphane
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/9
Y1 - 2020/9
N2 - The publisher regrets that the following corrections were missed during the publication of this article. Figure 2 legend is missing from the published article and should appear as follows: Figure 2: Overall survival from initiation of each life-extending therapy in accordance with the type of progression in 661 patients with mCRPC. (A) OS from first life-extending therapy (LET) initiation (all arms combined), (B) OS from second LET initiation (all arms combined), and (C) OS from third LET initiation (all arms combined). Referring to Table 3, ‘Median OS (all arms combined) in months’, the 1st LET entry for the Clin-p column should appear as 30.7 [27.5; 32.9]. Referring to Figure 2A, median Clin-p should appear as 30.7 [27.5; 32.9]. The correct Figure is included here The publisher would like to apologise for any inconvenience caused. [Figure presented]
AB - The publisher regrets that the following corrections were missed during the publication of this article. Figure 2 legend is missing from the published article and should appear as follows: Figure 2: Overall survival from initiation of each life-extending therapy in accordance with the type of progression in 661 patients with mCRPC. (A) OS from first life-extending therapy (LET) initiation (all arms combined), (B) OS from second LET initiation (all arms combined), and (C) OS from third LET initiation (all arms combined). Referring to Table 3, ‘Median OS (all arms combined) in months’, the 1st LET entry for the Clin-p column should appear as 30.7 [27.5; 32.9]. Referring to Figure 2A, median Clin-p should appear as 30.7 [27.5; 32.9]. The correct Figure is included here The publisher would like to apologise for any inconvenience caused. [Figure presented]
UR - http://www.scopus.com/inward/record.url?scp=85088795628&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088795628&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2020.06.013
DO - 10.1016/j.ejca.2020.06.013
M3 - Comment/debate
C2 - 32723589
AN - SCOPUS:85088795628
SN - 0959-8049
VL - 137
SP - 290
EP - 291
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -